OpenFilings

AXIM BIOTECHNOLOGIES, INC.

Form8-K

Report Period2023-01-23

Date Filed2023-01-27

Time Filed16:07:23

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
TL-66 CONVERTIBLE NOTES MODIFICATION AND DEFAULT WAIVER AGREEMENT DATED JANUARY
EXECUTIVE SETTLEMENT AGREEMENT DATED JANUARY 23, 2023
MMI CONVERTIBLE NOTE MODIFICATION AND DEFAULT WAIVER AGREEMENT DATED JANUARY 23,
IMAGE
Filing on SEC Edgar